Snowball logo
logo
SUPN_logo

Supernus Pharmaceuticals, Inc

SUPN β€’ NASDAQ
$45.11-$0.74Β  (1.61%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
579.8667.2607.5661.8719830.4
COGS
75.0687.2283.7877.9174.5699.03
Gross Profit
504.7580523.7583.9644.4731.4
Operating Expenses & Income
Operating Income
86.0346.12(5.269)81.67(36.86)(111.8)
Total Operating Expenses
418.7533.9529502.2681.3844.1
R&D Expenses
90.4774.5591.59108.8106.2126.1
Selling General & Admin Expenses
105109.4236.7247.3196.9307.8
Earnings from Continuing Operations
Interest Expense
(23.42)(7.07)(2.415)--(2.315)
Interest Income
10.5721.6910.8716.213.259.312
Income Tax Expense
19.750.0321.45324(10.48)(13.58)
Net Income
Net Income
53.4260.711.31673.86(38.55)(109.9)
Supplemental
EBIT
96.667.815.18497.87(49.03)(117.6)
EBITDA
129.2153.490.04178.342.53(15.87)
In millions of USD, except % and values per 1 share